Can GHK-Cu Make Dark Spots or Melasma Worse?
Published by AmpleLab Research
Two opposite claims circulate about copper peptides and skin colour. One says GHK-Cu fades dark spots and evens out tone. The other says that because copper is part of the enzyme that makes pigment, a copper serum could darken skin or aggravate melasma. Both sound plausible, and both are usually stated with more confidence than the research supports.
This article follows each claim back to its sources: what the biology of copper and pigment shows, where the "fades dark spots" line comes from, what is known about copper and melasma, and which causes of dark marks have far better evidence. AmpleLab sells a GHK-Cu serum, so we have a stake in the answer; the sources are linked so you can check them.
Why the Question Is Fair
Melanin is made by an enzyme called tyrosinase, and tyrosinase is a copper enzyme. A 2009 review of tyrosinase inhibitors describes its active site as holding two copper atoms. It describes the enzyme oxidising tyrosine, and then DOPA, to dopaquinone, and calls that first step the rate-limiting one in melanin synthesis.
A review of tyrosinase inhibitors. It describes the enzyme's binuclear copper centre, with the oxygen molecule bridging the two copper ions, and notes that several skin-lightening compounds, including kojic acid, are proposed to work in part by binding that copper. It is a review of enzyme chemistry, not a study of any copper peptide.
Copper supply also matters in living systems. In a 1979 study in mice, dietary copper deficiency and mutations that disturb copper handling reduced tyrosinase activity in hair-bulb extracts, and adding copper raised it again, though not fully to normal in one of the assays. The authors concluded that the mutations limited the copper available to pigment cells, so the enzyme was made but largely inactive. A later zebrafish study points the same way.
Chemical-genetic screens in zebrafish and yeast. The authors state that copper is essential for melanin production and that tyrosinase activity depends on the copper transporter ATP7A. In their embryo experiments, copper restored pigmentation in treated embryos, and a defect in protein trafficking caused pale pigmentation only when copper was limited. It is animal work on pigment cells, not a test of a topical product.
These findings share a pattern: copper limited pigment when it was scarce. They do not show the reverse, that supplying extra copper to cells that already have enough pushes pigment up. We found no study testing that for GHK-Cu in human skin. GHK-Cu is described as picking up copper from the blood protein albumin and acting as a delivery vehicle for copper ions locally, which is why the question comes up, but whether any of that copper reaches the pigment-making compartments of melanocytes after a cosmetic application has not been shown in anything we could find.
Where the "Fades Dark Spots" Claim Comes From
Some peptide guides quote figures such as a 30 to 50 percent reduction in the visibility of dark spots over several months, with no sample size or study attached. We traced the published trail behind the claim.
A widely cited review of GHK-Cu. Its cosmetic-use section says a GHK-Cu cream applied twice daily for 12 weeks reduced fine lines, coarse wrinkles and "mottled pigmentation". That sentence cites a 2005 book chapter rather than a trial paper. The thigh-skin study cited just before it, Abdulghani and colleagues in 1998, compared a copper peptide cream with vitamin C, melatonin and tretinoin in 20 volunteers and reported collagen synthesis, cell proliferation and inflammation markers; its abstract describes no pigmentation measurement.
The other source we found is a trade article on copper.org titled "Copper – an Antiaging Element". It quotes dermatologist James Leyden on Neutrogena products containing GHK-Cu, which it says improved laxity and "hyperpigmentation (brown spots)", and it says the study was done for Johnson & Johnson. It gives no sample size, control group or measurement method, and we could not find the full results in a journal.
A third source is easy to misread. A 2010 paper by Leyden and Parr reported improved mottled hyperpigmentation and lentigines in 42 women over 24 weeks, but the product was a proprietary copper zinc malonate lotion used with 4% hydroquinone and tretinoin. That is a different copper compound alongside two agents used for pigmentation, so it cannot be credited to copper, or to GHK-Cu.
None of the GHK-Cu papers we could read measured melanin or melanocyte activity directly. Our dark circles article makes the same point, that GHK-Cu's evidence base does not include melanin-suppressing activity, and our paper-by-paper research history lists what GHK-Cu has been tested for. On the evidence we could verify, "GHK-Cu fades pigmentation" is a hypothesis rather than a finding.
What About Copper and Melasma?
The worry has a second source: studies of copper in the blood of people with pigmentation disorders. A 1978 study in the Indian Journal of Dermatology, Venereology and Leprology compared 50 controls with 50 patients with hyperpigmentation and reported higher copper levels in these disorders; its abstract says that in females with melasma the main rise was in non-ceruloplasmin copper. It gave no numbers or statistics in the abstract.
That is an association in a small, almost fifty-year-old study, and it measured copper in the blood rather than copper applied to skin. It does not show that copper causes melasma, and a raised level could be a result of other factors rather than a driver. We could not locate more recent controlled work that settles it.
What the current melasma literature emphasises is different. A 2024 review in the American Journal of Clinical Dermatology links melasma to cumulative ultraviolet exposure, pregnancy, heat and contraceptive pill use. It treats photoprotection as central: in one 100-patient study broad-spectrum sunscreen alone improved melasma scores, and sunscreens containing iron oxide, which blocks visible light, did better than those without it. It describes hydroquinone as the long-standing gold-standard treatment.
The Better-Evidenced Risk: Irritation and Sun
A far better-documented route to dark marks than copper chemistry is inflammation. When skin is irritated, the inflammatory signals can stimulate pigment cells and leave a stain that outlasts the irritation.
A review of post-inflammatory hyperpigmentation. It describes the condition as overproduction or irregular dispersion of melanin after skin inflammation, notes that it occurs more commonly in skin of colour, and says it can worsen with UV exposure or with persistent or recurrent inflammation. The authors advise daily broad-spectrum sunscreen and caution that a treatment can itself cause or worsen it by causing irritation.
That puts the focus on whether a serum irritates your skin, whichever active it contains. Our guide to copper uglies covers the irritation reactions people report with copper peptides and how to reduce the chance of them, and our guide to using GHK-Cu covers application and routine. If you have darker skin or a history of marks lingering after spots or irritation, avoiding irritation is the practical priority, since the review reports that post-inflammatory hyperpigmentation is more common in skin of colour. We found no GHK-Cu trial that reports results by skin tone.
If You Are Prone to Dark Spots
None of the steps below has been tested specifically for GHK-Cu, so the first is the evidence-backed one and the rest are cautious reasoning.
Use sunscreen every day
Both reviews above treat UV protection as central to preventing and managing pigmentation. This holds whatever serum you use.
Patch test, then start slowly
A small test patch, then a few applications a week, lets you see how your skin responds before you commit. This is a precaution, not a result from a GHK-Cu trial.
Photograph your skin
A photo in the same light every few weeks shows whether a mark is fading, stable or spreading, which memory does badly.
Stop and get advice if something darkens
New darkening, persistent redness or marks that are spreading are a reason to pause the product and speak to a pharmacist or dermatologist. Melasma in particular is a diagnosis worth having made properly.
Our 1% GHK-Cu Face and Skin Serum page has the formulation, and the lab testing page has the independent HPLC report for the raw peptide. Neither changes what the pigmentation research shows, which is that the question is open.
Frequently Asked Questions
Can copper peptides cause hyperpigmentation?
We found no study showing that topical GHK-Cu increases pigmentation in people. The concern is reasonable in theory, because tyrosinase, the enzyme that makes melanin, contains copper. Animal and cell studies show copper limiting pigment when it is scarce, not boosting it when it is supplied to cells that already have enough. Irritation from any active ingredient can cause post-inflammatory hyperpigmentation, which is the better-documented route to dark marks.
Does GHK-Cu fade dark spots?
It has not been shown in a peer-reviewed trial that we could find. A 2018 review says GHK-Cu reduced mottled pigmentation but cites a 2005 book chapter for it, and a trade article describes a study of brown spots without a sample size or control group. A 2010 trial that improved hyperpigmentation used a different copper compound together with hydroquinone and tretinoin, so it cannot be credited to copper.
Is GHK-Cu safe to use if I have melasma?
We found no trial of GHK-Cu in melasma, so there is no evidence either way. Melasma is a chronic condition linked to ultraviolet exposure, pregnancy, heat and contraceptive pill use, and a 2024 review treats photoprotection as central to managing it. If you have melasma or are being treated for it, ask your dermatologist before adding any new active, and keep using sunscreen and any prescribed treatment.
Does high copper in the blood cause melasma?
That has not been shown. A small 1978 study reported higher non-ceruloplasmin copper in females with melasma, but it was an association, and copper in the blood is not the same as copper delivered to skin by a topical product. We could not find more recent controlled research that settles the question.
Is GHK-Cu suitable for darker skin tones?
We found no GHK-Cu trial that reports results by skin tone. Post-inflammatory hyperpigmentation is more common in skin of colour, so the practical priority is avoiding irritation: patch test, introduce the serum gradually, and use daily sunscreen.
Do I need sunscreen when using a copper peptide serum?
Yes. Sun protection is the best-supported step for anyone concerned about dark spots, whatever serum they use, because ultraviolet exposure can worsen existing pigmentation and is central to managing melasma. GHK-Cu has not been shown to replace or reduce the need for it.
Selected Research
This article is provided for educational purposes and does not constitute medical advice. AmpleLab products are cosmetic formulations and are not intended to diagnose, treat, cure, or prevent any condition.
AmpleLab.